These results indicate that 5-Aza-CdR treatment induces demethylation of CpG sites on ANO1 coding region in low-metastatic LNCap and DU145 prostate cancer cells and has no to very limited effects in highly-metastatic PC3 prostate cancer cells. The gene discussed is ANO1; the disease is prostate carcinoma.